ID

40777

Description

Effect Of Plasma Rich In Growth Factors In Knee Osteoarthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02039531

Link

https://clinicaltrials.gov/show/NCT02039531

Keywords

Versions (1)
  1. 5/11/20 5/11/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

May 11, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Knee Osteoarthritis NCT02039531

English

Eligibility Knee Osteoarthritis NCT02039531

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age above 55.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
moderate to severe symptoms according to the womac pain score of more than 6 months of evolution.
Description

Symptoms Moderate Pain WOMAC index | Severe symptoms Pain WOMAC index

Data type

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0205081
UMLS CUI [1,3]
C0030193
UMLS CUI [1,4]
C3472647
UMLS CUI [2,1]
C0436345
UMLS CUI [2,2]
C0030193
UMLS CUI [2,3]
C3472647
grade ii - iii knee osteoarthritis radiographic criteria for the classification of kellgren and lawrence.
Description

Knee Osteoarthritis Kellgren-Lawrence score

Data type

boolean

Alias
UMLS CUI [1,1]
C0409959
UMLS CUI [1,2]
C3177117
bmi index below 35 which is considered morbid obesity according to who.
Description

Body mass index | Morbid Obesity WHO classification

Data type

boolean

Alias
UMLS CUI [1]
C1305855
UMLS CUI [2,1]
C0028756
UMLS CUI [2,2]
C4267671
absence of treatments for osteoarthritis in the last 6 months.
Description

Treatment Absent Osteoarthritis

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0029408
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who have previously received medical treatment through viscosupplementation in the last 6 months.
Description

Viscosupplementation

Data type

boolean

Alias
UMLS CUI [1]
C2350507
patients who have allergies to some of the components of durolane ® either hyaluronic acid itself or any of its excipients.
Description

Hypersensitivity Sodium Hyaluronate Component | Hypersensitivity Hyaluronic Acid | Hypersensitivity Hyaluronic Acid Excipient

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0087000
UMLS CUI [1,3]
C1705248
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0020196
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0020196
UMLS CUI [3,3]
C0015237
patients with severe angular changes and joint instability.
Description

Change Angular Severe | Joint Instability

Data type

boolean

Alias
UMLS CUI [1,1]
C0392747
UMLS CUI [1,2]
C0205143
UMLS CUI [1,3]
C0205082
UMLS CUI [2]
C0022410
patients on anticoagulants or antiplatelet treatment that may not temporarily reversed for infiltrations.
Description

Anticoagulant therapy | Antiplatelet therapy

Data type

boolean

Alias
UMLS CUI [1]
C0150457
UMLS CUI [2]
C1096021
polyarticular disease
Description

POLYARTICULAR JOINT DISEASE

Data type

boolean

Alias
UMLS CUI [1]
C0747730
infectious diseases
Description

Communicable Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0009450
tumor processes on treatment or medical care.
Description

Cancer treatment

Data type

boolean

Alias
UMLS CUI [1]
C0920425
immunosuppressive therapy or immunosuppressive processes.
Description

Therapeutic immunosuppression | Immunosuppression

Data type

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C4048329
inability to understand the health questionnaires and / or adequately complete.
Description

Comprehension Questionnaires Unable | Completion Questionnaires Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C0034394
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0205197
UMLS CUI [2,2]
C0034394
UMLS CUI [2,3]
C1299582
Back to the top of the page

Similar models

Eligibility Knee Osteoarthritis NCT02039531

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age above 55.
boolean
C0001779 (UMLS CUI [1])
Symptoms Moderate Pain WOMAC index | Severe symptoms Pain WOMAC index
Item
moderate to severe symptoms according to the womac pain score of more than 6 months of evolution.
boolean
C1457887 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C0030193 (UMLS CUI [1,3])
C3472647 (UMLS CUI [1,4])
C0436345 (UMLS CUI [2,1])
C0030193 (UMLS CUI [2,2])
C3472647 (UMLS CUI [2,3])
Knee Osteoarthritis Kellgren-Lawrence score
Item
grade ii - iii knee osteoarthritis radiographic criteria for the classification of kellgren and lawrence.
boolean
C0409959 (UMLS CUI [1,1])
C3177117 (UMLS CUI [1,2])
Body mass index | Morbid Obesity WHO classification
Item
bmi index below 35 which is considered morbid obesity according to who.
boolean
C1305855 (UMLS CUI [1])
C0028756 (UMLS CUI [2,1])
C4267671 (UMLS CUI [2,2])
Treatment Absent Osteoarthritis
Item
absence of treatments for osteoarthritis in the last 6 months.
boolean
C0087111 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0029408 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Viscosupplementation
Item
patients who have previously received medical treatment through viscosupplementation in the last 6 months.
boolean
C2350507 (UMLS CUI [1])
Hypersensitivity Sodium Hyaluronate Component | Hypersensitivity Hyaluronic Acid | Hypersensitivity Hyaluronic Acid Excipient
Item
patients who have allergies to some of the components of durolane ® either hyaluronic acid itself or any of its excipients.
boolean
C0020517 (UMLS CUI [1,1])
C0087000 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0020196 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0020196 (UMLS CUI [3,2])
C0015237 (UMLS CUI [3,3])
Change Angular Severe | Joint Instability
Item
patients with severe angular changes and joint instability.
boolean
C0392747 (UMLS CUI [1,1])
C0205143 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C0022410 (UMLS CUI [2])
Anticoagulant therapy | Antiplatelet therapy
Item
patients on anticoagulants or antiplatelet treatment that may not temporarily reversed for infiltrations.
boolean
C0150457 (UMLS CUI [1])
C1096021 (UMLS CUI [2])
POLYARTICULAR JOINT DISEASE
Item
polyarticular disease
boolean
C0747730 (UMLS CUI [1])
Communicable Diseases
Item
infectious diseases
boolean
C0009450 (UMLS CUI [1])
Cancer treatment
Item
tumor processes on treatment or medical care.
boolean
C0920425 (UMLS CUI [1])
Therapeutic immunosuppression | Immunosuppression
Item
immunosuppressive therapy or immunosuppressive processes.
boolean
C0021079 (UMLS CUI [1])
C4048329 (UMLS CUI [2])
Comprehension Questionnaires Unable | Completion Questionnaires Unable
Item
inability to understand the health questionnaires and / or adequately complete.
boolean
C0162340 (UMLS CUI [1,1])
C0034394 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0205197 (UMLS CUI [2,1])
C0034394 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial